Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12626
PUT
Lifecore Biomedical
LFCR
$179M
| $18.5K | ﹤0.01% |
3,600
-12,400
| -78% | -$73.4K |
|
|
JBIO
12627
CALL
Jade Biosciences
JBIO
$1.57B
| $18.4K | ﹤0.01% |
+317
| New | +$210K |
|
12628
Lumen
LUMN
$6.93B
| $18.4K | ﹤0.01% |
16,747
-727,669
| -98% | -$923K |
|
12629
CALL
AdvisorShares Psychedelics ETF
PSIL
$52.6M
| $18.4K | ﹤0.01% |
+1,880
| New | +$23.2K |
|
12630
PUT
Legacy Housing
LEGH
$698M
| $18.4K | ﹤0.01% |
800
-19,400
| -96% | -$427K |
|
12631
PUT
ClearPoint Neuro
CLPT
$468M
| $18.3K | ﹤0.01% |
3,400
-1,800
| -35% | -$10.4K |
|
|
RJET
12632
PUT
Republic Airways Holdings
RJET
$952M
| $18.3K | ﹤0.01% |
713
+626
| +720% | +$10.2K |
|
12633
PUT
Mistras Group
MG
$576M
| $18.2K | ﹤0.01% |
2,200
+2,100
| +2,100% | +$18.4K |
|
|
API
12634
PUT
Agora
API
$392M
| $18.2K | ﹤0.01% |
8,600
+4,300
| +100% | +$10.8K |
|
12635
PUT
Oxford Square Capital
OXSQ
$157M
| $18.2K | ﹤0.01% |
6,200
+4,500
| +265% | +$14K |
|
|
UBX
12636
CALL
DELISTED
Unity Biotechnology
UBX
| $18.2K | ﹤0.01% |
13,500
+8,900
| +193% | +$13.5K |
|
12637
PUT
RLX Technology
RLX
$2.37B
| $18.2K | ﹤0.01% |
9,900
+3,200
| +48% | +$6.05K |
|
|
AKYA
12638
DELISTED
Akoya BioSciences
AKYA
| $18.2K | ﹤0.01% |
7,772
-52,826
| -87% | -$168K |
|
12639
CALL
Nature's Sunshine
NATR
$266M
| $18.1K | ﹤0.01% |
+1,200
| New | +$20.5K |
|
|
LOGC
12640
DELISTED
ContextLogic
LOGC
| $18.1K | ﹤0.01% |
3,165
-23,044
| -88% | -$127K |
|
|
TBRG
12641
CALL
DELISTED
TruBridge
TBRG
| $18K | ﹤0.01% |
1,800
+600
| +50% | +$5.47K |
|
|
ZH
12642
CALL
Zhihu
ZH
$272M
| $18K | ﹤0.01% |
6,592
-641
| -9% | -$2.35K |
|
12643
CLPS Inc
CLPS
$25.8M
| $18K | ﹤0.01% |
20,269
+1,852
| +10% | +$1.77K |
|
12644
CALL
Data I/O
DAIO
$32.9M
| $17.9K | ﹤0.01% |
6,500
+5,100
| +364% | +$15.8K |
|
12645
Abeona Therapeutics
ABEO
$343M
| $17.9K | ﹤0.01% |
4,230
+4,226
| +105,650% | +$21.6K |
|
12646
CALL
Microvast
MVST
$322M
| $17.9K | ﹤0.01% |
39,300
-16,800
| -30% | -$7.54K |
|
12647
PUT
Mueller Water Products
MWA
$3.99B
| $17.9K | ﹤0.01% |
1,000
-9,500
| -90% | -$163K |
|
12648
CALL
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $17.9K | ﹤0.01% |
800
-21,600
| -96% | -$496K |
|
12649
CALL
Sportradar
SRAD
$4.09B
| $17.9K | ﹤0.01% |
1,600
-171,000
| -99% | -$1.78M |
|
12650
Castellum
CTM
$61.8M
| $17.9K | ﹤0.01% |
96,128
-71,709
| -43% | -$16.6K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.